Shaskyyla Cotton
Family · Lagrange, GANPI 1417551102
Payments from drug & device makers
Across 89 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$591
- Boston Scientific$135
- Merck$130
- Amgen$110
- Pfizer$106
- Kiniksa Pharmaceuticals International, PLC$67
- plus $386 from 14 others
What the payments were for
- Food & beverage$1,526100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $591 |
| Boston Scientific | 6 | $135 |
| Merck | 8 | $130 |
| Amgen | 6 | $110 |
| Pfizer | 4 | $106 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $67 |
| G Medical Diagnostic Services, Inc. | 4 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Cardiovascular Systems Inc. | 5 | $53 |
| Smith+Nephew | 1 | $40 |
| Novartis | 1 | $28 |
| Medicomp Inc | 1 | $23 |
| Medtronic | 1 | $23 |
| BD | 1 | $18 |
| Veryan Medical Incorporated | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Bioventus LLC | 1 | $14 |
| Terumo Medical Corporation | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $10 |
How this compares
$1,526 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $61,263 |
| XareltoRivaroxaban | 51 | $33,289 |
| EntrestoSacubitril/Valsartan | 31 | $24,756 |
| BrilintaTicagrelor | 19 | $11,745 |
| FarxigaDapagliflozin Propanediol | 13 | $9,968 |
| Metoprolol Succinate | 98 | $854 |
| Atorvastatin Calcium | 111 | $532 |
| Prasugrel Hcl | 15 | $497 |
| Carvedilol | 90 | $386 |
| Lisinopril | 53 | $241 |
| Amlodipine Besylate | 61 | $231 |
| ClopidogrelClopidogrel Bisulfate | 37 | $231 |
| Amiodarone Hcl | 11 | $223 |
| Metoprolol Tartrate | 77 | $216 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $106 | $61,26368 claims |
| Johnson & JohnsonXarelto | $591 | $33,28951 claims |
| NovartisEntresto | $28 | $24,75631 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.
Other family in Lagrange
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.